Aristotle Atlantic Partners, LLC, an investment advisor, released its “Core Equity Strategy” third-quarter 2025 investor ...
Medtronic plc offers stable dividends and consistent cash flow, but growth remains lackluster with revenues plateauing. Read ...
Dietitians are not just end-users of AI tools. They can be cocreators, leaders, and subject matter experts on AI projects. In ...
DexCom's growth rate has been improving, but that hasn't been enough of a reason for investors to buy up the stock.
The Vivo V70 has appeared on Geekbench with the Snapdragon 7 Gen 4, 8GB RAM and Android 16, hinting at an early 2026 launch.
Zacks Investment Research on MSN
Here's Why You Should Hold DexCom Stock in Your Portfolio for Now
DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by a huge potential in the CGM market. A strong third-quarter 2025 performance and a series of favorable coverage decisions ...
The Paramount and Skydance merger, which was announced in 2024, was officially completed in August 2025. The company’s Q3 ...
StockStory.org on MSN
Winners And Losers Of Q3: DexCom (NASDAQ:DXCM) Vs The Rest Of The Patient Monitoring Stocks
Looking back on patient monitoring stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including DexCom ...
In no surprise, Team Red is trying to power more AI in the laptop space with its upcoming 'Gorgon' and 'Medusa' chips.
With both the Vivo V70 and V70 Lite appearing in certifications and benchmarks, the series launch now seems closer.
This week, Tandem Diabetes Care (Nasdaq:TNDM) announced a major milestone for its Mobi miniature durable insulin pump system.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback